Chargement en cours...
Epidermal growth factor receptor and variant III targeted immunotherapy
Immunotherapeutic approaches to cancer have shown remarkable promise. A critical barrier to successfully executing such immune-mediated interventions is the selection of safe yet immunogenic targets. As patient deaths have occurred when tumor-associated antigens shared by normal tissue have been tar...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4207138/ https://ncbi.nlm.nih.gov/pubmed/25342601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou236 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|